Development of a Cortical Visual Neuroprosthesis for the Blind
CORTIVIS
Pilot Study for the Development of a Cortical Visual Neuroprosthesis for the Blind Based on Intracortical Microelectrodes
1 other identifier
interventional
5
1 country
2
Brief Summary
The objective of this study is to evaluate the usefulness of a cortical visual prosthesis based on intracortical microelectrodes to provide a limited but useful sense of vision to profoundly blind. This pilot study will provide important information on safety and efficacy for the development of an useful cortical visual neuroprosthesis for the blind.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2016
CompletedFirst Posted
Study publicly available on registry
December 6, 2016
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
May 5, 2026
April 1, 2026
8.2 years
September 12, 2016
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Thresholds of visual perceptions elicited by intracortical microstimulation
Charges needed for eliciting visual perceptions through electrical stimulation of the human cortex
Within implantation period (up to 6 months)
Secondary Outcomes (5)
Phosphene mapping
Within implantation period (up to 6 months)
Visual Acuity
Within implantation period (up to 6 months)
Motion perception
Within implantation period (up to 6 months)
Visual function
Within implantation period (up to 6 months)
Number of participants with significant adverse events.
Within implantation period (up to 6 months)
Study Arms (1)
Blind volunteer
EXPERIMENTALBlind volunteers will be implanted with our existing vision neuroprosthetic system, which utilizes a FDA cleared microelectrode array, using a minicraniotomy. The array will be implanted near the occipital pole or in extra striate areas. The investigators will collect descriptive feedback regarding thresholds, evoked perceptions and stimulation parameters leading to recognizable patterns.
Interventions
The surgical method for the implantation of the intracortical microelectrodes is straightforward and follows the standard neurosurgical procedures. Briefly, after the scalp is prepped with an antiseptic, a small skin incision is made. Then the skin and muscles are lifted off from the bone and folded back. Next, one small burr hole or a minicraniotomy of approximately 1.5 cm is made in the skull. This is a minimally invasive procedure that allows an easy access to the brain and is a standard procedure widely used in neurosurgery.
Eligibility Criteria
You may qualify if:
- Participant is capable and willing to provide informed consent for participation in the trial.
- Severe visual impairment with bilateral visual loss.
- Greater than 18 years of age.
- General health: excellent.
- Following a general physical and neurological examination, patient must have normal serum electrolytes, C-reactive protein, complete blood count and PT and PTT.
- No history of stroke, seizure, coagulopathy, cardiac arrhythmias or ischemia, pulmonary, hepatic or renal disease, nor transmissible viruses such as hepatitis or HIV.
- Stable dose of current regular medication for at least four weeks prior to trial entry.
- Able to perform the study during the full time period of up to 6 months.
- Special consideration will be given to patients with (1) detailed medical histories, including documentation of the onset, mechanism and evolution of the blindness; (2) lower risks associated with surgery; and (3) no psychiatric disorders or other mental disabilities.
You may not qualify if:
- Age \<18 or \>70.
- Period of appropriate visual functions \< 12 years /lifetime.
- For medical reasons: Individuals with a history of seizure disorders, coagulopathy, cardiac arrythmias or ischemia, pulmonary, hepatic or renal disease, and any other neurological disorder. Patients who carry a transmissible virus such as hepatitis and individuals with HIV-related neuropathies.
- Vulnerable subject groups (e.g., pregnant women, prisoners, etc.).
- Persons unable to give written informed consent prior to participation in the study.
- Not able to perform the study during the full time period (at least 3 months).
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Miguel Hernandez de Elchelead
- Hospital IMED Elchecollaborator
Study Sites (2)
Hospital IMED Elche
Elche, Alicante, 03202, Spain
Universidad Miguel Hernandez de Elche
Elche, Alicante, 03202, Spain
Related Publications (24)
Martinez-Alvarez A, Crespo-Cano R, Diaz-Tahoces A, Cuenca-Asensi S, Ferrandez Vicente JM, Fernandez E. Automatic Tuning of a Retina Model for a Cortical Visual Neuroprosthesis Using a Multi-Objective Optimization Genetic Algorithm. Int J Neural Syst. 2016 Nov;26(7):1650021. doi: 10.1142/S0129065716500210. Epub 2016 Mar 29.
PMID: 27354187BACKGROUNDAlfaro A, Bernabeu A, Agullo C, Parra J, Fernandez E. Hearing colors: an example of brain plasticity. Front Syst Neurosci. 2015 Apr 14;9:56. doi: 10.3389/fnsys.2015.00056. eCollection 2015.
PMID: 25926778BACKGROUNDFernandez E, Greger B, House PA, Aranda I, Botella C, Albisua J, Soto-Sanchez C, Alfaro A, Normann RA. Acute human brain responses to intracortical microelectrode arrays: challenges and future prospects. Front Neuroeng. 2014 Jul 21;7:24. doi: 10.3389/fneng.2014.00024. eCollection 2014.
PMID: 25100989BACKGROUNDNormann RA, Greger B, House P, Romero SF, Pelayo F, Fernandez E. Toward the development of a cortically based visual neuroprosthesis. J Neural Eng. 2009 Jun;6(3):035001. doi: 10.1088/1741-2560/6/3/035001. Epub 2009 May 20.
PMID: 19458403BACKGROUNDWarren DJ, Fernandez E, Normann RA. High-resolution two-dimensional spatial mapping of cat striate cortex using a 100-microelectrode array. Neuroscience. 2001;105(1):19-31. doi: 10.1016/s0306-4522(01)00174-9.
PMID: 11483297BACKGROUNDMaynard EM, Fernandez E, Normann RA. A technique to prevent dural adhesions to chronically implanted microelectrode arrays. J Neurosci Methods. 2000 Apr 15;97(2):93-101. doi: 10.1016/s0165-0270(00)00159-x.
PMID: 10788663BACKGROUNDMorillas CA, Romero SF, Martinez A, Pelayo FJ, Ros E, Fernandez E. A design framework to model retinas. Biosystems. 2007 Feb;87(2-3):156-63. doi: 10.1016/j.biosystems.2006.09.009. Epub 2006 Sep 7.
PMID: 17011701BACKGROUNDFernandez E, Pelayo F, Romero S, Bongard M, Marin C, Alfaro A, Merabet L. Development of a cortical visual neuroprosthesis for the blind: the relevance of neuroplasticity. J Neural Eng. 2005 Dec;2(4):R1-12. doi: 10.1088/1741-2560/2/4/R01. Epub 2005 Nov 29.
PMID: 16317227BACKGROUNDMarin C, Fernandez E. Biocompatibility of intracortical microelectrodes: current status and future prospects. Front Neuroeng. 2010 May 28;3:8. doi: 10.3389/fneng.2010.00008. eCollection 2010.
PMID: 20577634BACKGROUNDBernabeu A, Alfaro A, Garcia M, Fernandez E. Proton magnetic resonance spectroscopy (1H-MRS) reveals the presence of elevated myo-inositol in the occipital cortex of blind subjects. Neuroimage. 2009 Oct 1;47(4):1172-6. doi: 10.1016/j.neuroimage.2009.04.080. Epub 2009 May 5.
PMID: 19426816BACKGROUNDNormann RA, Fernandez E. Clinical applications of penetrating neural interfaces and Utah Electrode Array technologies. J Neural Eng. 2016 Dec;13(6):061003. doi: 10.1088/1741-2560/13/6/061003. Epub 2016 Oct 20.
PMID: 27762237BACKGROUNDFernandez E, Alfaro A, Soto-Sanchez C, Gonzalez-Lopez P, Lozano AM, Pena S, Grima MD, Rodil A, Gomez B, Chen X, Roelfsema PR, Rolston JD, Davis TS, Normann RA. Visual percepts evoked with an intracortical 96-channel microelectrode array inserted in human occipital cortex. J Clin Invest. 2021 Dec 1;131(23):e151331. doi: 10.1172/JCI151331.
PMID: 34665780BACKGROUNDKucukoglu B, Soo L, Leeftink D, Grani F, Soto Sanchez C, Guclu U, van Gerven M, Fernandez E. Bayesian optimization of cortical neuroprosthetic vision using perceptual feedback. J Neural Eng. 2025 Jul 24;22(4). doi: 10.1088/1741-2552/adeae9.
PMID: 40602416RESULTAlfaro A, Soo L, Waclawczyk D, Morollon R, Grani F, Fernandez E. The unexpected sight: improvement of visual function following intracortical microstimulation of the human occipital cortex. Brain Commun. 2026 Feb 3;8(1):fcaf504. doi: 10.1093/braincomms/fcaf504. eCollection 2026.
PMID: 41788163RESULTLozano A, Chen X, La Grouw M, Li B, Wang F, van der Grinten M, Soto-Sanchez C, Morales-Gregorio A, Fernandez E, Roelfsema PR. Large-scale mapping of artificial perceptions for neuroprostheses using spontaneous neuronal activity in macaque and human visual cortex. Brain Stimul. 2026 Jan-Feb;19(1):103019. doi: 10.1016/j.brs.2025.103019. Epub 2025 Dec 29.
PMID: 41475513RESULTGrani F, Soto-Sanchez C, Rodil Doblado A, Lopez Peco R, Gonzalez-Lopez P, Fernandez E. Neural correlates of phosphene perception in blind individuals: A step toward a bidirectional cortical visual prosthesis. Sci Adv. 2025 Nov 7;11(45):eadv8846. doi: 10.1126/sciadv.adv8846. Epub 2025 Nov 5.
PMID: 41191758RESULTRuiz RM, Garces JAC, Soo L, Fernandez E. Enhancing Orientation and Mobility Assessments: Integrating Visual and Auditory Factors Using Artificial Intelligence Tools. Transl Vis Sci Technol. 2025 Jul 1;14(7):14. doi: 10.1167/tvst.14.7.14.
PMID: 40689721RESULTWaclawczyk D, Soo L, Morollon Ruiz R, Caspi A, Fernandez E. Integrating Eye-Tracking With Cortical Visual Prostheses in Patients Without Eyes: A Case Study. IEEE Trans Neural Syst Rehabil Eng. 2025;33:3998-4007. doi: 10.1109/TNSRE.2025.3615286.
PMID: 41021945RESULTLopez-Peco R, Val-Calvo M, Soto-Sanchez C, Villamarin-Ortiz A, Ruiz-Boix G, Ferrandez-Vicente JM, Fernandez E. Neuronal Waveform Classification in Multielectrode Recordings Using Machine Learning Techniques and Multidimensional Analysis. Int J Neural Syst. 2025 Jun;35(6):2550031. doi: 10.1142/S0129065725500315.
PMID: 40375639RESULTFarfan FD, Soo L, Grani F, Grima-Murcia MD, Fernandez E. Brain connectivity changes in response to cortical electrical stimulation in blind neuroprosthesis users. Cereb Cortex. 2025 Apr 1;35(4):bhaf075. doi: 10.1093/cercor/bhaf075.
PMID: 40173310RESULTFernandez E, Robles JA. Advances and challenges in the development of visual prostheses. PLoS Biol. 2024 Oct 24;22(10):e3002896. doi: 10.1371/journal.pbio.3002896. eCollection 2024 Oct.
PMID: 39446886RESULTRocca A, Lehner C, Wafula-Wekesa E, Luna E, Fernandez-Cornejo V, Abarca-Olivas J, Soto-Sanchez C, Fernandez-Jover E, Gonzalez-Lopez P. Robot-assisted implantation of a microelectrode array in the occipital lobe as a visual prosthesis: technical note. J Neurosurg. 2023 Oct 27;140(4):1169-1176. doi: 10.3171/2023.8.JNS23772. Print 2024 Apr 1.
PMID: 37890180RESULTGrani F, Soto-Sanchez C, Fimia A, Fernandez E. Toward a personalized closed-loop stimulation of the visual cortex: Advances and challenges. Front Cell Neurosci. 2022 Dec 13;16:1034270. doi: 10.3389/fncel.2022.1034270. eCollection 2022.
PMID: 36582211RESULTGrani F, Soto-Sanchez C, Farfan FD, Alfaro A, Grima MD, Rodil Doblado A, Fernandez E. Time stability and connectivity analysis with an intracortical 96-channel microelectrode array inserted in human visual cortex. J Neural Eng. 2022 Jul 22;19(4). doi: 10.1088/1741-2552/ac801d.
PMID: 35817011RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eduardo Fernandez, MD and PhD
Universidad Miguel Hernandez de Elche
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD and PhD
Study Record Dates
First Submitted
September 12, 2016
First Posted
December 6, 2016
Study Start
October 1, 2019
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
October 1, 2028
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share